Skip to main content

Advertisement

Log in

Involvement of P-Glycoprotein in the Transport of Saquinavir and Indinavir in Rat Brain Microvessel Endothelial and Microglia Cell Lines

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Membrane-bound efflux transporters, such as P-glycoprotein (P-gp), may limit the brain entry and distribution of HIV-1 protease inhibitors and be in part responsible for HIV-1-associated dementia treatment failure. The purpose of this study was to characterize the transport properties of saquinavir and indinavir in a brain microvessel endothelial cell line and in microglia, the immune cells of the brain and primary HIV-1 cellular target.

Methods. Biochemical and transport studies were performed in an immortalized rat brain endothelial cell line (RBE4), a rat microglia cell line (MLS-9), and a P-gp overexpressing Chinese hamster ovary cell line (CHRC5).

Results. Western blot analysis using the P-gp monoclonal antibody C219 detected a single band at approximately 170 to 180 kDa (a size previously reported for P-gp) in all cell lines. Cellular accumulation of [14C]saquinavir and [3H]indinavir by RBE4, MLS-9, and CHRC5 monolayers was significantly enhanced in the presence of P-gp inhibitors, HIV-1 protease inhibitors, the ATPase inhibitor sodium azide, and the ATP depleting agent 2',4'-dinitrophenol respectively. [14C]Saquinavir and [3H]indinavir efflux from both cell systems was rapid and significantly reduced in the presence of PSC833.

Conclusions. These results provide evidence for P-gp mediated transport of saquinavir and indinavir in RBE4 and MLS-9 and suggest that this transporter can restrict, at least in part, the permeation of HIV-1 protease inhibitors at both the brain barrier site and in brain parenchyma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

references

  1. J. C. McArthur, N. Haughey, S. Gartner, K. Conant, C. Pardo, A. Nath, and N. Sacktor. Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 9:205–221 (2003).

    Google Scholar 

  2. M. Kaul, G. A. Garden, and S. A. Lipton. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988–994 (2001).

    Google Scholar 

  3. A. E. Kim, J. M. Dintaman, D. S. Waddell, and J. A. Silverman. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. J. Pharmacol. Exp. Ther. 286:1439–1445 (1998).

    Google Scholar 

  4. N. Sacktor, R. H. Lyles, R. Skolasky, C. Kleeberger, O. A. Selnes, E. N. Miller, J. T. Becker, B. Cohen, and J. C. McArthur. and Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56:257–260 (2001).

  5. S. Kravcik, G. Victor, J. B. Angel, A. D. Badley, G. E. Garber, and D. W. Cameron. Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy. Clin. Infect. Dis. 29:702–703 (1999).

    Google Scholar 

  6. A. H. Schinkel, U. Mayer, E. Wagenaar, C. A. Mol, L. van Deemter, J. J. Smit, M. A. van der Valk, A. C. Voordouw, H. Spits, O. van Tellingen, J. M. Zijlmans, W. E. Fibbe, and P. Borst. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94:4028–4033 (1997).

    Google Scholar 

  7. R. B. Kim, M. F. Fromm, C. Wandel, B. Leake, A. J. Wood, D. M. Roden, and G. R. Wilkinson. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101:289–294 (1998).

    Google Scholar 

  8. E. F. Choo, B. Leake, C. Wandel, H. Imamura, A. J. Wood, G. R. Wilkinson, and R. B. Kim. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab. Dispos. 28:655–660 (2000).

    Google Scholar 

  9. R. L. Juliano and V. Ling. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455:152–162 (1976).

    Google Scholar 

  10. M. M. Gottesman, C. A. Hrycyna, P. V. Schoenlein, U. A. Germann, and I. Pastan. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29:607–649 (1995).

    Google Scholar 

  11. J. J. Smit, A. H. Schinkel, R. P. Oude Elferink, A. K. Groen, E. Wagenaar, L. van Deemter, C. A. Mol, R. Ottenhoff, N. M. van der Lugt, and M. A. van Roon. et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462 (1993).

    Google Scholar 

  12. C. B. Washington, H. R. Wiltshire, M. Man, T. Moy, S. R. Harris, E. Worth, P. Weigl, Z. Liang, D. Hall, L. Marriott, and T. F. Blaschke. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells. Drug Metab. Dispos. 28:1058–1062 (2000).

    Google Scholar 

  13. V. V. Rao, J. L. Dahlheimer, M. E. Bardgett, A. Z. Snyder, R. A. Finch, A. C. Sartorelli, and D. Piwnica-Worms. Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebro-spinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA 96:3900–3905 (1999).

    Google Scholar 

  14. E. Beaulieu, M. Demeule, L. Ghitescu, and R. Beliveau. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem. J. 326:539–544 (1997).

    Google Scholar 

  15. P. L. Golden and W. M. Pardridge. P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res. 819:143–146 (1999).

    Google Scholar 

  16. G. Lee, L. Schlichter, M. Bendayan, and R. Bendayan. Functional expression of P-glycoprotein in rat brain microglia. J. Pharmacol. Exp. Ther. 299:204–212 (2001).

    Google Scholar 

  17. R. Bendayan, G. Lee, and M. Bendayan. Functional expression and localization of P-glycoprotein at the blood-brain barrier. Microsc. Res. Tec. 57:365–380 (2002).

    Google Scholar 

  18. D. J. Begley, D. Lechardeur, Z. D. Chen, C. Rollinson, M. Bardoul, F. Roux, D. Scherman, and N. J. Abbott. Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J. Neurochem. 67:988–995 (1996).

    Google Scholar 

  19. F. Roux, O. Durieu-Trautmann, N. Chaverot, M. Claire, P. Mailly, J. M. Bourre, A. D. Strosberg, and P. O. Couraud. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol. 159:101–113 (1994).

    Google Scholar 

  20. A. Regina, A. Koman, M. Piciotti, and B. El Hafny. M.S. Center, R. Bergmann, P.O. Couraud and F. Roux. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. 71:705–715 (1998).

    Google Scholar 

  21. W. Zhou, F. S. Cayabyab, P. S. Pennefather, L. C. Schlichter, and T. E. DeCoursey. HERG-like K+ channels in microglia. J. Gen. Physiol. 111:781–794 (1998).

    Google Scholar 

  22. S. Dallas, X. Zhu, S. Baruchel, L. Schlichter, and R. Bendayan. Functional expression of the multidrug resistance protein 1 (MRP1) in microglia. J. Pharmacol. Exp. Ther. 307:282–290 (2003).

    Google Scholar 

  23. E. Georges, G. Bradley, J. Gariepy, and V. Ling. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:152–156 (1990).

    Google Scholar 

  24. C. G. L. Lee, M. M. Gottesman, C. O. Cardarelli, M. Ramachandra, K. T. Jeang, S. V. Ambudkar, I. Pastan, and S. Dey. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37:3594–3601 (1998).

    Google Scholar 

  25. H. Gutmann, G. Fricker, J. Drewe, M. Toeroek, and D. S. Miller. Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol. Pharmacol. 56:383–389 (1999).

    Google Scholar 

  26. G. J. Dore, P. K. Correll, Y. Li, J. M. Kaldor, D. A. Cooper, and B. J. Brew. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:1249–1253 (1999).

    Google Scholar 

  27. L. C. Schlichter, G. Sakellaropoulos, B. Ballyk, P. S. Pennefather, and D. J. Phipps. Properties of K+ and Cl- channels and their involvement in proliferation of rat microglia cells. Glia 17:225–236 (1996).

    Google Scholar 

  28. J. Drewe, H. Gutmann, G. Fricker, M. Torok, C. Beglinger, and J. Huwyler. HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem. Pharmacol. 57:1147–1152 (1999).

    Google Scholar 

  29. S. P. Cole and R. G. Deeley. Multidrug resistance mediated by the ATP-binding cassette ransporter protein MRP. Bioessays 20:931–940 (1998).

    Google Scholar 

  30. P. Borst, R. Evers, M. Kool, and J. Wijnholds. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:1295–1302 (2000).

    Google Scholar 

  31. Y. Zhang, H. Han, W. F. Elmquist, and D. W. Miller. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res. 876:148–153 (2000).

    Google Scholar 

  32. J. Hirrlinger, J. Konig, and R. Dringen. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J. Neurochem. 82:716–719 (2002).

    Google Scholar 

  33. K. Jones, P. G. Bray, S. H. Khoo, R. A. Davey, E. R. Meaden, S. A. Ward, and D. J. Back. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance? AIDS 15:1353–1358 (2001).

    Google Scholar 

  34. G. C. Williams, A. Liu, G. Knipp, and P. J. Sinko. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob. Agents Chemother. 46:3456–3462 (2002).

    Google Scholar 

  35. W. Zhang, J. Mojsilovic-Petrovic, M. F. Andrade, H. Zhang, M. Ball, and D. B. Stanimirovic. Expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17:2085–2087 (2003).

    Google Scholar 

  36. T. Eisenblätter, S. Hüwel, and H. Galla. Characterization of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Res. 971:221–231 (2003).

    Google Scholar 

  37. L. A. Doyle, W. Yang, L. V. Abruzzo, T. Krogmann, Y. Gao, A. K. Rishi, and D. D. Ross. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95:15665–15670 (1998).

    Google Scholar 

  38. T. Litman, T. E. Druley, W. D. Stein, and S. E. Bates. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58:931–959 (2001).

    Google Scholar 

  39. L. A. Doyle and D. D. Ross. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22:7340–7358 (2003).

    Google Scholar 

  40. A. Gupta, Y. Zhang, J. D. Unadkat, and Q. Mao. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J. Pharmacol. Exp. Ther. In Press (2004).

  41. P. T. Ronaldson, M. Bendayan, D. Gingras, M. Piquette-Miller, and R. Bendayan. Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J. Neurochem. In Press (2004).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reina Bendayan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ronaldson, P.T., Lee, G., Dallas, S. et al. Involvement of P-Glycoprotein in the Transport of Saquinavir and Indinavir in Rat Brain Microvessel Endothelial and Microglia Cell Lines. Pharm Res 21, 811–818 (2004). https://doi.org/10.1023/B:PHAM.0000026433.27773.47

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000026433.27773.47

Navigation